
Bright Peak Therapeutics, Inc. has raised $90.0M in total funding. The most recent round was Series C.
Bright Peak Therapeutics, Inc. is headquartered in Del Mar, CA.
Bright Peak uses proprietary protein engineering to develop next-generation multifunctional precision immunotherapies for treating cancer.
The site claims 'world-class' proprietary protein engineering capabilities used to design multifunctional biologics through chemistry.
Bright Peak Therapeutics was founded in 2017 by Vijaya Pattabiraman and Jeffrey Bode and raised a $90M Series C backed by Versant Ventures, Fidelity, RA Capital, and the Qatar Investment Authority.
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated August 26, 2026.